Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.

[1]  J. Shuster,et al.  Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906 , 2011, Pediatric blood & cancer.

[2]  Michael N. Alonso,et al.  B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies , 2011, Nature Medicine.

[3]  N. Heisterkamp,et al.  Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist , 2011, Leukemia.

[4]  C. Pui,et al.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  L. Ricci-Vitiani,et al.  Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells. , 2010, Endocrine-related cancer.

[6]  S. Ryu,et al.  Targeted label-free quantitative analysis of secretory proteins from adipocytes in response to oxidative stress. , 2010, Analytical biochemistry.

[7]  N. Heisterkamp,et al.  A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias. , 2010, Cancer research.

[8]  I. Petit,et al.  Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia? , 2010, Seminars in cancer biology.

[9]  G. Colditz,et al.  Obesity and Cancer , 2010, The oncologist.

[10]  S. Mittelman,et al.  Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice. , 2010, Pharmacological research.

[11]  N. Heisterkamp,et al.  Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia , 2010, Leukemia.

[12]  C. Dive,et al.  Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.

[13]  Z. Estrov,et al.  Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. , 2009, Blood.

[14]  N. Heisterkamp,et al.  Adipocytes impair leukemia treatment in mice. , 2009, Cancer research.

[15]  F. Visseren,et al.  Obesity and Cancer: The Role of Dysfunctional Adipose Tissue , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[16]  C. Jung,et al.  Association of waist circumference, traditional cardiovascular risk factors, and stromal‐derived factor‐1 in adolescents , 2009, Pediatric diabetes.

[17]  M. Lafontan,et al.  Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. , 2009, Biochemical and biophysical research communications.

[18]  J. Fenton,et al.  Diet‐induced adiposity alters the serum profile of inflammation in C57BL/6N mice as measured by antibody array , 2009, Diabetes, obesity & metabolism.

[19]  Shao-fen Lin,et al.  Upregulation of stromal cell–derived factor 1 (SDF-1) expression in microvasculature endothelial cells in retinal ischemia-reperfusion injury , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  V. Hombach,et al.  T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Bleyer,et al.  Obesity and outcome in pediatric acute lymphoblastic leukemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Galinier,et al.  Weight-dependent changes of immune system in adipose tissue: importance of leptin. , 2006, Experimental cell research.

[23]  C. Massone,et al.  Rimming of Adipocytes By Neoplastic Lymphocytes: A Histopathologic Feature Not Restricted to Subcutaneous T-Cell Lymphoma , 2006, The American Journal of dermatopathology.

[24]  M. Vignetti,et al.  Obesity Independently Predicts Event Free Survival (EFS) in Adults with BCR-ABL-Negative Acute Lymphoblastic Leukemia (ALL). A Retrospective Analysis of Two GIMEMA Studies. , 2005 .

[25]  Y. Miyake,et al.  CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease , 2005, Clinical and experimental immunology.

[26]  G. Botti,et al.  Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells , 2005, Cancer Immunology, Immunotherapy.

[27]  A. Galinier,et al.  Adipose tissues as an ancestral immune organ: Site‐specific change in obesity , 2005, FEBS letters.

[28]  A. Bleyer,et al.  Obesity and Body Weight Independently Predict Relapse and Survival in Preadolescents and Teenagers with Acute Lymphoblastic Leukemia (ALL). A Retrospective Analysis of Five Children Cancer Group (CCG) Studies. , 2004 .

[29]  A. Beaudet,et al.  Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. , 2004, Obesity research.

[30]  A. Nagler,et al.  Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling. , 2004, Blood.

[31]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[32]  Puneeth Iyengar,et al.  Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization , 2003, Oncogene.

[33]  C. Darimont,et al.  Reconstitution of telomerase activity combined with HPV-E7 expression allow human preadipocytes to preserve their differentiation capacity after immortalization , 2003, Cell Death and Differentiation.

[34]  J. Juarez,et al.  Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro , 2003, Leukemia.

[35]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[36]  Evan T Keller,et al.  Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.

[37]  N R Schneider,et al.  Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. , 2001, American journal of clinical pathology.

[38]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[39]  Bernhard Moser,et al.  Lymphocyte traffic control by chemokines , 2001, Nature Immunology.

[40]  L. Gibson,et al.  Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. , 2000, Blood.

[41]  R. Alon,et al.  The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. , 2000, Blood.

[42]  S. Rafii,et al.  The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. , 1998, Blood.

[43]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[44]  F. Behm,et al.  Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. , 1997, Blood.

[45]  T. Springer,et al.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.

[46]  F. Behm,et al.  Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. , 1994, Blood.

[47]  G. Buchanan.  Diagnosis and management of relapse in acute lymphoblastic leukemia. , 1990, Hematology/oncology clinics of North America.

[48]  A. Peled,et al.  CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers , 2009, Leukemia.

[49]  A. Fielding.  The treatment of adults with acute lymphoblastic leukemia. , 2008, Hematology. American Society of Hematology. Education Program.

[50]  C. Dive,et al.  Obesity and cancer: Pathophysiological and biological mechanisms , 2008, Archives of physiology and biochemistry.

[51]  N. Heisterkamp,et al.  A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl , 2004, Leukemia.